EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Diagnostic Yield of [ 18 F]FDG PET/CT in FUO: An Italian Multicenter Study of 929 Patients

Domenico Albano, Francesco Lanfranchi, Matteo Bauckneht, Michela Massollo, Arnoldo Piccardo, Michele Balma, Simona Peano, Virginia Liberini, Alessandro Coccarelli, Silvia Morbelli, Riccardo Laudicella, Giulia Giacoppo und 17 weitere

Journal of Nuclear Medicine · 2026

DOI: 10.2967/jnumed.125.271525 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Nuclear Medicine, 2026. Verfasst von Domenico Albano und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, University of Brescia, Brescia, Italy; domenico.albano@unibs.it. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography, Fever of Unknown Origin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fever of unknown origin (FUO) presents a significant diagnostic challenge because of its wide range of potential causes. The role of [18F]FDG PET/CT in this complex clinical scenario is not yet fully understood. This multicenter retrospective observational study aimed to investigate the diagnostic value and clinical impact of [18F]FDG PET/CT in patients with FUO and to identify specific factors linked to a positive [18F]FDG PET/CT scan.

Methods

We retrospectively included 929 patients from 12 centers who underwent [18F]FDG PET/CT for FUO. The final diagnosis for each patient was established on the basis of laboratory, imaging, histopathologic or pathologic examinations, and at least 6 mo of clinical follow-up data. Final diagnoses were classified into 4 categories: infectious diseases, noninfectious inflammatory diseases, malignancies, and unknown causes (no diagnosis). Moreover, the impact of [18F]FDG PET/CT on clinical management, as well as its association with clinical, epidemiologic, and biochemical parameters were analyzed.

Results

The final diagnoses included infectious diseases in 332 patients (36%), noninfectious inflammatory diseases in 281 (30%), and malignancies in 103 (11%). The cause of FUO remained undiagnosed in 213 patients (23%). [18F]FDG PET/CT scans had positive results for 549 (59%) patients and negative for the remaining 380 patients. The overall [18F]FDG PET/CT sensitivity was 72% (95% CI, 69%-75%), specificity was 85% (95% CI, 79%-89%), positive predictive value was 94% (95% CI, 92%-96%), negative predictive value was 47% (95% CI, 44%-51%), and accuracy was 75% (95% CI, 72%-78%). Predictive markers for a positive PET/CT scan were high C-reactive protein, high erythrocyte sedimentation rate, high neutrophil-to-lymphocyte ratio, the presence of fever at the time of PET, and short duration of prior antibiotic therapy. Moreover, [18F]FDG PET/CT findings directly influenced the clinical management of approximately 75% of patients. Conclusion: [18F]FDG PET/CT is a high-yield diagnostic tool that directly influenced clinical management of approximately 75% of patients with FUO, with optimal performance in patients with elevated inflammatory markers, fever at the time of imaging, and limited prior antibiotic use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18Positron Emission Tomography Computed TomographyFever of Unknown OriginHumansFemaleMaleItalyRetrospective StudiesMiddle AgedAgedAdultAged, 80 and overAdolescentYoung AdultRadiopharmaceuticalsSensitivity and Specificity

Stichwörter der Autor:innen

FDGFUOPET/CTfever of unknown origininfectious disease

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Nuclear Medicine, University of Brescia, Brescia, Italy; domenico.albano@unibs.it.
  • Department of Nuclear Medicine, ASST Spedali Civili di Brescia, Brescia, Italy.
  • Department of Health Science, University of Genoa, Genoa, Italy.
  • Department of Nuclear Medicine, E.O. Ospedali Galliera, Genoa, Italy.
  • Department of Nuclear Medicine, S. Croce e Carle, Cuneo, Italy.
  • Department of Nuclear Medicine, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.

Zitieren

APA

Albano, D., Lanfranchi, F., Bauckneht, M., Massollo, M., Piccardo, A., Balma, M., Peano, S., Liberini, V., Coccarelli, A., Morbelli, S., Laudicella, R., Giacoppo, G., Capitanio, S., Franchini, A., Muni, A., Miceli, A., Piva, R., Abenavoli, E., Linguanti, F., …, & Bertagna, F. (2026). Diagnostic Yield of [ 18 F]FDG PET/CT in FUO: An Italian Multicenter Study of 929 Patients. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.125.271525

Vancouver

Albano D, Lanfranchi F, Bauckneht M, Massollo M, Piccardo A, Balma M, et al. Diagnostic Yield of [ 18 F]FDG PET/CT in FUO: An Italian Multicenter Study of 929 Patients. Journal of Nuclear Medicine. 2026. doi:10.2967/jnumed.125.271525

BibTeX
@article{Albano2026,
  author = {Albano, Domenico and Lanfranchi, Francesco and Bauckneht, Matteo and Massollo, Michela and Piccardo, Arnoldo and Balma, Michele and Peano, Simona and Liberini, Virginia and Coccarelli, Alessandro and Morbelli, Silvia and Laudicella, Riccardo and Giacoppo, Giulia and Capitanio, Selene and Franchini, Annalisa and Muni, Alfredo and Miceli, Alberto and Piva, Roberta and Abenavoli, Elisabetta and Linguanti, Flavia and Filice, Angelina and Durmo, Rexhep and Ferrari, Cristina and Battisti, Claudia and Rubini, Giuseppe and Santo, Giulia and Busnardo, Elena and Chiti, Arturo and Deandreis, Desiree and Bertagna, Francesco},
  title = {Diagnostic Yield of [ 18 F]FDG PET/CT in FUO: An Italian Multicenter Study of 929 Patients},
  journal = {Journal of Nuclear Medicine},
  year = {2026},
  doi = {10.2967/jnumed.125.271525}
}
Kostenlos starten →